Skip to content

Pediatric Chronic Rhinosinusitis in Asthmatic Children

Management of Pediatric Chronic Rhinosinusitis in Asthmatic Children

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06194097
Enrollment
0
Registered
2024-01-08
Start date
2017-07-25
Completion date
2020-07-25
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinusitis in Children

Brief summary

The objectives of this study would be to determine the most effective treatment for children with PCRS and asthma who fail medical management.

Detailed description

This prospective, randomized study would involve children age 6-12 with symptoms of both PCRS and asthma. Their symptoms would first be managed medically with standard medical therapy. In the event they fail medical management, patients would then be randomized to two treatment arms, either adenoidectomy alone or adenoidectomy with ESS. CT scan of the sinuses would then be obtained to evaluate the extent of sinus disease and aid in preoperative planning in those patients undergoing ESS. Sinus mucosa thickening seen on CT is also integral in the diagnosis of PCRS, according to consensus statements published by the American Academy of Otolaryngology. At each visit patient's symptoms would be measured with the SN-5, a validated questionnaire for tracking PCRS.

Interventions

PROCEDUREadenoidectomy versus endoscopic sinus surgery with adenoidectomy

adenoidectomy versus endoscopic sinus surgery

Sponsors

State University of New York - Upstate Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria: Age 6-12 at time of study enrollment. Presence of chronic sinusitis: \>90 days 2 or more symptoms of purulent rhinorrhea, nasal obstruction, facial pressure/pain, or cough with corresponding endoscopic and/or CT findings in a patient 18 years or younger. Presence of asthma, as documented in the medical record by the patient's pediatrician and/or pulmonologist

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frame
surgical outcome1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026